United Kingdom information. Medicine licences and NHS services described here apply to the UK; they may not apply where you live.
Home / Medications / BenzatropineAbout this translation / Información
Saved AI-generated translation, without independent bilingual clinical review. Medicine names, original references and image labels stay in their original language. The USA or UK edition stays the same.Traducción guardada generada por IA, sin revisión clínica bilingüe independiente. Los nombres de medicamentos, las referencias originales y las etiquetas de las imágenes conservan su idioma original. Se mantiene la edición de EE. UU. o del Reino Unido.
La versión en español ya está guardada en este sitio. Al elegir Español no se envía el artículo a un servicio de traducción.
Psychiatry AtlasMedication guide · United Kingdom
Benzatropine
Generic name
Benzatropine (also called benztropine)
Medication class
Antimuscarinic anticholinergic medicine
How it’s taken
An imported injection may be given into a muscle or a vein by trained healthcare staff. Overseas tablets do not establish UK oral-product availability.
Selected formulation
Article updated: 2026-10-24
United Kingdom information. Medicine licences and NHS services described here apply to the UK; they may not apply where you live.
Benzatropine, also called benztropine, is an anticholinergic medicine. Current UK guidance describes imported injection use for acute dystonia; the foreign oral and injectable products must not be represented as UK-licensed brands.
UK source information
Primary sources and supporting references identify the UK products, licences and guidance covered. Information is provided for general education, not personalised prescribing advice. Shared medication science does not establish UK product approvals, dosing instructions or NHS treatment pathways.
No UK brand name verified within this article’s scope
Type of medicine
Antimuscarinic anticholinergic medicine
Uses at a Glance
Current UK guidance covers unlicensed imported injection for acute dystonic reactions; this is not a UK marketing authorisation.
Available strengths
No UK-licensed strength or self-treatment regimen is presented. Emergency dosing belongs to the treating clinician and the actual imported product's instructions.
An imported injection may be given into a muscle or a vein by trained healthcare staff. Overseas tablets do not establish UK oral-product availability.
Forms and brands are not automatically interchangeable. Product information does not guarantee local stock or NHS funding.
Benzatropine and benztropine are names for the same active medicine. Current NHS Specialist Pharmacy Service advice describes unlicensed imported injection for acute dystonic reactions, including reactions caused by antipsychotics or antiemetics. It is inaccurate either to call this a UK-licensed product or to say that it has no UK clinical context.
An acute dystonic reaction is a sudden abnormal contraction or posture, not a diagnosisDiagnosisA clinical conclusion about the condition that best explains a person’s symptoms and other findings.Read the full definition of Diagnosis that can be made from any tremor or restlessness. Correctly identifying the movement problem matters because anticholinergic treatment is not appropriate for every medicine-related movement disorder.
What is this medicine used for?
The verified UK context is clinician-managed acute dystonia. Foreign information also describes treatment of parkinsonian symptoms, but that does not establish a UK oral licence, a preferred Parkinson's treatment or a recommendation for long-term preventive use.
Benzatropine is not a treatment for tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them. and may worsen it. An apparently similar movement problem may therefore require a different response. Imported use still requires a clinical rationale and an accountable treatment plan.
Which warning signs need help?
Acute dystonia can be an emergency, particularly when swallowing or breathing is affected. Suspected serious reactions need urgent medical assessment, not self-treatment with leftover medicines.
After anticholinergic exposure, hot dry skin with fever, severe confusion or hallucinationsHallucinationsA hallucination is a sensory experience without a corresponding external source—for example, hearing a voice when nobody is speaking. It can involve hearing, sight, touch, smell or taste and may feel very real.A hallucination is an experience; a delusion is a belief. Hallucinations can have different causes, so an assessment is needed to understand them., inability to pass urine, severe abdominal symptoms, collapse or seizure can indicate serious toxicity. Severe allergy also needs urgent assessment. Reduced sweating can make overheating dangerous.
How do I take it safely?
The verified UK route of access is an unlicensed imported injection, administered into a muscle or a vein. No UK-licensed brand or strength is asserted, and this article does not reproduce an emergency dosing calculation.
Foreign oral tablets are discussed in overseas patient information. That is useful background for an existing prescription, not proof of present UK oral supply. The specific product, ingredients and instructions must be established by the supplying pharmacy; the New Zealand data sheet linked here does not prove that its named manufacturer's product is stocked in the UK.
What side effects should I know about?
Dry mouth, constipation, nausea and difficulty passing urine can occur. Blurred vision, drowsiness and a rapid pulse also matter. Persistent or worsening effects need clinical assessment rather than being treated as evidence that the medicine is working.
Alcohol can increase drowsiness. Do not drive or undertake hazardous tasks when alertness or vision is affected.
Who needs extra care with this medicine?
Glaucoma, urinary obstruction or an enlarged prostate, bowel obstruction, tachycardia, cognitive impairment and vulnerability to psychosisPsychosisPsychosis describes symptoms that affect a person’s ability to tell what is real. These can include hallucinations, delusions and disorganised thinking or speech.Psychosis can occur with different mental or physical health conditions, some medicines or substance use. It does not automatically mean schizophrenia. New symptoms need prompt professional assessment. require particular attention. Exact contraindicationsA medical reason a medicine should not be usedA medical reason a medicine should not be used in a particular situation because it may be harmful.Read the full definition of Contraindication must be checked against the supplied product; the linked foreign data sheet is not a UK SmPC.
Do not assume that new involuntary movements are always a reason to add benzatropine. Tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them. is a particularly important exception, and cognitive or behavioural deterioration can itself be an adverse effect.
Can it affect my other medicines?
Anticholinergic effects can accumulate across medicines. Current UK advice specifically highlights people already taking procyclidine or trihexyphenidyl who then require injectable benzatropine. More than one medicine affecting the same system can increase harm without adding useful benefit.
Tricyclic antidepressants, some antipsychotics, sedating medicines and alcohol also need review. Include non-prescription medicines and supplements in the medication history rather than relying on a short list of named interactions.
What check-ups will I need?
Assess relief of the movement problem alongside alertness, pulse, temperature, bowel and bladder function, and the cumulative effects of other medicines. Continued treatment deserves review after the causative medicine or clinical situation changes.
Imported emergency stock also requires clear product identification, records and local oversight. An educational account cannot confirm that a particular ward has the medicine or that a repeat prescription is appropriate.
What about pregnancy, breastfeeding and age?
UK guidance states that use is contraindicated below three years of age. Older children still require an appropriately trained clinician; an adult emergency regimen must not be scaled informally.
Pregnancy and breastfeeding evidence is limited in the reviewed product information, so individual benefit–risk assessment is needed. Older adults can be more vulnerable to confusion, urinary and other anticholinergic effects. Age alone does not answer whether emergency treatment is justified.
What if I miss a dose or want to stop?
A one-off emergency injection is not the same as a regular oral prescription. If somebody already takes benzatropine regularly, changes should be agreed with the treating team: sudden withdrawalWithdrawalSymptoms that may occur after reducing or stopping a medicine or substance to which the body has adapted.Read the full definition of Withdrawal can allow movement symptoms to return.
For an existing oral regimen, do not double a dose to compensate for one missed. Follow the actual dispensed instructions and seek pharmacy advice where the plan or supply is unclear.
How does it work?
Benzatropine reduces the effect of acetylcholine, a chemical messenger involved in movement and many other body functions. It blocks muscarinic receptorsReceptorA protein that recognizes a signal and helps a cell respond. Different receptor types can produce different responses to the same messenger.Read the full definition of Receptor, proteins that receive acetylcholine’s messages.
This blocking action is called antimuscarinic or anticholinergic. It can help certain movement problems, including stiffness and shaking when dopamineDopamineA chemical messenger involved in movement, learning and emotion. Its name does not describe one feeling or one role throughout the brain.Read the full definition of Dopamine signaling has been reduced. Dopamine is another chemical messenger involved in movement.
Benzatropine does not replace dopamine or cure the underlying condition. The same receptor action can also affect memory and thinking, reduce saliva, slow the bowel and make it harder to empty the bladder. A benefit for one kind of movement problem does not mean it helps every movement a person cannot control.
How does it affect my body?
PharmacodynamicsWhat a medication does to the bodyWhat a medication does to the body, including its intended effects and other effects.Read the full definition of Pharmacodynamics means what a medicine does to the body. Reducing acetylcholine signalling can lessen certain movement symptoms, but the same action affects attention, memory, salivary glands, the gut, bladder and sweat glands. Benefit and unwanted effects can occur together.
The treatment goal is observable improvement in the correctly identified movement problem, not simply sedation. Confusion, constipation, difficulty passing urine and impaired cooling in hot conditions are meaningful effects of the same pharmacology.
How does my body process it?
The reviewed labels do not provide a sufficiently detailed modern account of oral bioavailability, elimination half-lifeThe time for a measured drug level to fall by halfThe time it takes for the concentration of a medicine in a body fluid, usually blood, to decrease by half during elimination.Read the full definition of Half-life or enzyme pathways to justify precise values here. Numbers should not be inferred from another anticholinergic or from the speed of symptom relief.
UK advice describes a similar onset for injection into a muscle and into a vein, with effects that may persist beyond the immediate emergency. Repeated treatment can add to anticholinergic burden; route selection and observation belong to trained clinicians.
How do treatment options differ?
Benzatropine, procyclidine and trihexyphenidyl share anticholinergic properties but are not interchangeable by name or by milligram. NHS SPS reports no established dose equivalence between benzatropine injection and procyclidine.
Choice also depends on the movement disorder. A medicine that relieves acute dystonia may be unsuitable for tardive dyskinesiaTardive dyskinesiaTardive dyskinesia is a movement disorder that can develop after exposure to certain medicines, particularly antipsychotics. It causes repeated movements that the person does not intend, such as lip-smacking, chewing motions or tongue movements; other body areas can be affected.The movements may persist after the medicine is stopped. Report new involuntary movements to your prescriber; medication changes should be planned with them.; shared involvement of movement does not mean a shared treatment.
A closer look at the science
Benzatropine mesylate is a salt of the active molecule and methanesulfonic acid. The parent molecule has formula C21H25NO; its salt partner is CH4O3S. These describe chemical composition, not a product strength or dosing instruction.
The structure combines features associated with atropine and diphenhydramine. The foreign data sheet describes both anticholinergic and antihistaminic activity, but the latter is not established as the explanation for benefit in parkinsonism. A molecular resemblance is not a substitution rule.
How was this medicine developed?
The current UK guidance was developed after procyclidine injection was discontinued from the UK market. Its September 2026 update provides a concrete supply and governance context for imported benzatropine.
This is a change in practical access and emergency-service preparation, not evidence of a new UK marketing authorisation. Historical foreign product names and oral use do not establish the present availability of any brand in Britain.
US National Library of Medicine / DailyMed · Accessed 2026-10-24
Scope: Mechanism explanation only. Source sections checked: Clinical Pharmacology; Indications; Precautions; Adverse Reactions. This does not establish UK product authorisation or prescribing..
Primary research, Journal of Pharmacology and Experimental Therapeutics / NLM PubMed · Accessed 2026-10-24
Scope: Mechanism explanation only. Source sections checked: Abstract: receptor-binding experiment. This does not establish UK product authorisation or prescribing..
Listed with each reference above; retained dates for shared scientific content.
Scope
UK acute-dystonia unlicensed-import context plus ingredient pharmacology and general safety; overseas oral use clearly distinguished.
Source and coverage limits
No UK oral-product availability, named imported brand or current pharmacy stock is asserted.
The Medsafe label is foreign product evidence for science and safety, not proof that this exact product is imported into the UK.
NHS-login supply details were not accessed; no credential or access bypass was attempted.
Detailed emergency dosing and a prescribing conversion are deliberately outside this public educational article; treating clinicians must use the actual product and applicable professional guidance.